ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.
M. Ignatiadis1, H.L. McArthur2, A. Bailey3, J. Martinez4, E. de Azambuja1, O. Metzger5, C. Lai6, M.A. Franzoi7, T. Goulioti8, F. Daly9, A. Bouhlel10, V. Balta11, M. Maetens1, G. Viale12, B. André7, C. DuFRane13, D.A. Nguyen10, R.D. Gelber14, M. Piccart15, E.P. Winer16
Comunicaciones en congresos
Abstract
ESMO
2019
IMpassion030
